This randomized trial evaluates the efficacy of a novel photo-activated crosslinking approach, suggesting advanced capabilities for genetic applications.
We introduce 3-CF 3 - p -phenylenediamine-L-lysine, a genetically encodable photo-Defluorination-Acyl Fluoride Exchange ncAA. It features red-shifted activation (311 → 365 nm) for faster photo-defluorination relative to 1 st generation photo-DAFEx ncAA, and subsequent Ac-F...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: